Profil
Jon Ellis is currently a Director at Orchard Therapeutics (Europe) Ltd. He was previously an Independent Non-Executive Director at Orchard Therapeutics Plc from 2018 to 2021.
Prior to that, he was the VP & Head-Technology Business Development at GSK Plc from 2019 to 2022.
Dr. Ellis holds a doctorate degree from the University of Cambridge, an MBA from Henley Management College, and undergraduate and graduate degrees from Magdalene College.
Aktiva positioner av Jon Ellis
| Företag | Position | Start |
|---|---|---|
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Direktör/Styrelseledamot | 2018-08-02 |
Tidigare kända positioner av Jon Ellis
| Företag | Position | Slut |
|---|---|---|
| GSK PLC | Teknisk/Vetenskaplig/F&U Direktör | 2022-08-01 |
| ORCHARD THERAPEUTICS PLC | Direktör/Styrelseledamot | 2021-06-16 |
Jon Elliss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Henley Management College
Henley Management College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magdalene College
Magdalene College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orchard Therapeutics (Europe) Ltd.
Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Researches on transformative gene therapies | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
















